OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
22
Results
Show all
Save search
Copy query
Show results for
Unknown
(22)
Publication Date
Release Date
2023
(6)
2022
(5)
2021
(4)
2024
(2)
2012
(2)
2025
(1)
2020
(1)
2018
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Activation of kinin B1 receptor evokes hyperthermia through a vagal sensory mechanism in the rat.
Not available
S-EPMC3460782
|
biostudies-literature
Cite
Randomized phase II study of dacomitinib (PF-00299804), an irreversible pan-human epidermal growth factor receptor inhibitor, versus erlotinib in patients with advanced non-small-cell lung cancer.
Not available
S-EPMC5321098
|
biostudies-literature
Cite
NREM sleep oscillations and their relations with sleep-dependent memory consolidation in early course psychosis and first-degree relatives.
Not available
S-EPMC10634996
|
biostudies-literature
Cite
SARS-CoV-2 infection among healthcare workers: the role of occupational and household exposures during the first three pandemic waves in Quebec, Canada.
Not available
S-EPMC10654992
|
biostudies-literature
Cite
Physical, Psychological, and Cognitive Profile of Post-COVID Conditions in Healthcare Workers, Quebec, Canada.
Not available
S-EPMC9379818
|
biostudies-literature
Cite
Risk and protective factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare workers: A test-negative case-control study in Quebec, Canada.
Not available
S-EPMC9530374
|
biostudies-literature
Cite
Replication Study: Transcriptional amplification in tumor cells with elevated c-Myc.
Not available
S-EPMC5760205
|
biostudies-literature
Cite
Genetic structuring among colonies of a pantropical seabird: Implication for subspecies validation and conservation.
Not available
S-EPMC7663974
|
biostudies-literature
Cite
Early and intensive motor training to enhance neurological recovery in people with spinal cord injury: trial protocol.
Not available
S-EPMC10495259
|
biostudies-literature
Cite
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study.
Not available
S-EPMC9757903
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets